FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912673265> ?p ?o ?g. }

• W2912673265 endingPage "2401" @default.
• W2912673265 startingPage "2401" @default.
• W2912673265 abstract "Abstract The Severe Chronic Neutropenia International Registry (SCNIR) in cooperation with Washington University has developed a next-generation sequencing assay for the genetic diagnosis of chronic neutropenia. Exome-based sequencing is performed, and genetic alterations in 27 genes implicated in the pathogenesis of severe congenital neutropenia (SCN) are reported. Of note, with consent, patients are enrolled in the SCNIR to collect detailed clinical data and to allow researchers access to the exome sequence data to identify new genetic alterations contributing to disease pathogenesis, severity, and progression to acute myeloid leukemia. Here, we report sequencing results for 61 cases of SCN, 31 cases of cyclic neutropenia, and 3 cases of idiopathic or unclassified neutropenia. The median age of this cohort was 17.2 years (range 0.13 to 78 years). Ninety-eight per cent of the SCN cases received G-CSF with a median dose of 1.85 mg/kg/day (range, 0-99.3), and 87% of cyclic neutropenia cases received G-CSF with a median dose of 0.34 mg/kg/day (range, 0-5.2). ELANE mutation status was previously determined for the majority of these cases. In total, 16 of 95 cases of neutropenia had a known ELANE mutation, and the remainder of the cases had no genetic diagnosis. Initial analyses focused on the following genes previously implicated in SCN pathogenesis: ELANE, AP3B1, CSF3R, CXCR2, CXCR4, G6PC3, GFI1, HAX1, LYST, LAMTOR2, RAB27A, SBDS, SLC37A4, SRP54, TCIRG1, VPS13B, VPS45, USB1, TAZ, and WAS. Heterozygous mutations of ELANE were identified in the 16 previously identified cases, but in no additional cases. Of the remaining 50 cases of SCN, probable pathogenic mutations were identified in 8 (16%). Surprisingly, in the 27 cases of cyclic neutropenia with wildtype ELANE, no probable pathogenic mutations were identified. We identified three cases of SCN (including two family members) with biallelic mutations of G6PC3 and single cases of SCN with N382S GFI or R184C TCIRG1 mutations. A novel homozygous R547X CSF3R mutation was seen in one case of SCN. This truncation mutation in the extracellular domain of the G-CSF receptor is predicted to result in a complete loss-of-function allele. Indeed, this patient was refractory to G-CSF therapy. We also identified a single case of SCN carrying a R338X CXCR4 mutation, the cause of WHIM syndrome. Of note, emerging data suggest that the neutropenia in WHIM syndrome can be effectively treated with CXCR4 antagonists. We identified two cases of SCN carrying heterozygous mutations of SRP54, G175E and T191I, respectively. These SRP54 mutations, although not previously reported, localize to the GTPase domain of SRP54 (similar to previously identified SRP54 mutations), and they have not been identified in over 60,000 individuals in the ExAC database. Conclusions: Extended genetic testing in patients with chronic neutropenia and wildtype ELANE, although identifying a pathogenic mutation in the minority of cases, may impact the choice of therapy. Analyses of the exome sequence data are underway to identify novel candidate genes contributing to neutropenia. Disclosures Dale: Athelas, Inc.: Equity Ownership; Amgen: Consultancy, Research Funding; Sanofi-Aventi: Consultancy, Honoraria; Cellerant: Other: Scientific Advisory Board; Hospira: Consultancy; Prolong: Consultancy; Beheringer-Ingelheim: Consultancy; Coherus: Consultancy." @default.
• W2912673265 created "2019-02-21" @default.
• W2912673265 creator A5014066022 @default.
• W2912673265 creator A5015520404 @default.
• W2912673265 creator A5039505336 @default.
• W2912673265 creator A5049284725 @default.
• W2912673265 creator A5062422889 @default.
• W2912673265 creator A5082170535 @default.
• W2912673265 date "2018-11-29" @default.
• W2912673265 modified "2023-09-27" @default.
• W2912673265 title "Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy" @default.
• W2912673265 doi "https://doi.org/10.1182/blood-2018-99-116712" @default.
• W2912673265 hasPublicationYear "2018" @default.
• W2912673265 type Work @default.
• W2912673265 sameAs 2912673265 @default.
• W2912673265 citedByCount "1" @default.
• W2912673265 countsByYear W29126732652022 @default.
• W2912673265 crossrefType "journal-article" @default.
• W2912673265 hasAuthorship W2912673265A5014066022 @default.
• W2912673265 hasAuthorship W2912673265A5015520404 @default.
• W2912673265 hasAuthorship W2912673265A5039505336 @default.
• W2912673265 hasAuthorship W2912673265A5049284725 @default.
• W2912673265 hasAuthorship W2912673265A5062422889 @default.
• W2912673265 hasAuthorship W2912673265A5082170535 @default.
• W2912673265 hasBestOaLocation W29126732651 @default.
• W2912673265 hasConcept C104317684 @default.
• W2912673265 hasConcept C10590036 @default.
• W2912673265 hasConcept C126322002 @default.
• W2912673265 hasConcept C143998085 @default.
• W2912673265 hasConcept C16671776 @default.
• W2912673265 hasConcept C203014093 @default.
• W2912673265 hasConcept C2776694085 @default.
• W2912673265 hasConcept C2777063308 @default.
• W2912673265 hasConcept C2778527355 @default.
• W2912673265 hasConcept C2908751872 @default.
• W2912673265 hasConcept C501734568 @default.
• W2912673265 hasConcept C54355233 @default.
• W2912673265 hasConcept C71924100 @default.
• W2912673265 hasConcept C86803240 @default.
• W2912673265 hasConceptScore W2912673265C104317684 @default.
• W2912673265 hasConceptScore W2912673265C10590036 @default.
• W2912673265 hasConceptScore W2912673265C126322002 @default.
• W2912673265 hasConceptScore W2912673265C143998085 @default.
• W2912673265 hasConceptScore W2912673265C16671776 @default.
• W2912673265 hasConceptScore W2912673265C203014093 @default.
• W2912673265 hasConceptScore W2912673265C2776694085 @default.
• W2912673265 hasConceptScore W2912673265C2777063308 @default.
• W2912673265 hasConceptScore W2912673265C2778527355 @default.
• W2912673265 hasConceptScore W2912673265C2908751872 @default.
• W2912673265 hasConceptScore W2912673265C501734568 @default.
• W2912673265 hasConceptScore W2912673265C54355233 @default.
• W2912673265 hasConceptScore W2912673265C71924100 @default.
• W2912673265 hasConceptScore W2912673265C86803240 @default.
• W2912673265 hasIssue "Supplement 1" @default.
• W2912673265 hasLocation W29126732651 @default.
• W2912673265 hasOpenAccess W2912673265 @default.
• W2912673265 hasPrimaryLocation W29126732651 @default.
• W2912673265 hasRelatedWork W2519975593 @default.
• W2912673265 hasRelatedWork W2573688106 @default.
• W2912673265 hasRelatedWork W2896691718 @default.
• W2912673265 hasRelatedWork W2912673265 @default.
• W2912673265 hasRelatedWork W3100654809 @default.
• W2912673265 hasRelatedWork W3211378293 @default.
• W2912673265 hasRelatedWork W3216456674 @default.
• W2912673265 hasRelatedWork W4223439668 @default.
• W2912673265 hasRelatedWork W4229032128 @default.
• W2912673265 hasRelatedWork W3129521408 @default.
• W2912673265 hasVolume "132" @default.
• W2912673265 isParatext "false" @default.
• W2912673265 isRetracted "false" @default.
• W2912673265 magId "2912673265" @default.
• W2912673265 workType "article" @default.